Kintsugi develops AI-driven voice biomarker technology to detect signs of depression and anxiety from brief, free-form speech samples. Their primary offering, Kintsugi Voice, is an API-first platform that integrates with call centers, telehealth systems, and remote patient monitoring applications to identify mental health challenges in real time. This technology analyzes vocal features without relying on the content of speech, enabling language-agnostic assessments.

Paige offers an AI-powered digital pathology platform designed to assist pathologists in diagnosing cancer and other diseases from pathology slides. The platform includes tools for detecting, quantifying, and visualizing tumor areas, providing decision support and streamlining workflows. Paige's AI models are trained on large datasets of pathology images and integrate with existing lab systems to enhance diagnostic accuracy and efficiency in clinical settings.

Syntrillo is developing an AI-enabled telehealth platform aimed at preventing strokes by integrating data from wearable devices and clinical records to monitor and manage patients' stroke risk. The platform features an automated disease monitoring system that models patient risk and behavior, generates personalized prevention plans, and includes an AI virtual assistant providing 24/7 support to patients and providers. Additionally, Syntrillo offers access to a remote care team comprising neurologists, nurse practitioners, and rehabilitation specialists to ensure comprehensive care.